Cancer Immunotherapy: Factors Important for the Evaluation of Safety in Nonclinical Studies
Crossref DOI link: https://doi.org/10.1208/s12248-017-0184-3
Published Online: 2018-02-07
Published Print: 2018-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Herzyk, Danuta J.
Haggerty, Helen G.
Text and Data Mining valid from 2018-02-07
Article History
Received: 13 October 2017
Accepted: 27 December 2017
First Online: 7 February 2018